Antiangiogenic therapy: impact on invasion, disease progression, and metastasis

Por Ebos, John M. L., Kerbel, Robert S.
Publicado no Nat Rev Clin Oncol (2011)

Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy

Por Ebos, John M.L., Lee, Christina R., Kerbel, Robert S.
Publicado em 2009

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy

Por Tracz, Amanda, Mastri, Michalis, Lee, Christina R., Pili, Roberto, Ebos, John M. L.
Publicado em 2014

Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy

Por Ebos, John M. L., Lee, Christina R., Christensen, James G., Mutsaers, Anthony J., Kerbel, Robert S.
Publicado em 2007

Classical Mathematical Models for Description and Prediction of Experimental Tumor Growth

Por Benzekry, Sébastien, Lamont, Clare, Beheshti, Afshin, Tracz, Amanda, Ebos, John M. L., Hlatky, Lynn, Hahnfeldt, Philip
Publicado em 2014

Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

Por Ebos, John M.L., Lee, Christina R., Cruz-Munoz, William, Bjarnason, Georg A., Christensen, James G., Kerbel, Robert S.
Publicado no Cancer Cell (2009)